# A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer

> **NCT00215345** · PHASE2 · UNKNOWN · sponsor: **Department of Veterans Affairs, New Jersey** · enrollment: 66 (—)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Taxotere
- **DRUG:** Celecoxib

## Key facts

- **NCT ID:** NCT00215345
- **Lead sponsor:** Department of Veterans Affairs, New Jersey
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-08
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 66 (—)
- **Last updated:** 2005-09-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00215345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00215345, "A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00215345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*